Loading...
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Public Library of Science
2013
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3665796/ https://ncbi.nlm.nih.gov/pubmed/23724057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0064526 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|